Abstract
Unlike NF1 or NF2 variants in patients with neurofibromatosis type 1 or 2, mosaicism for SMARCB1 or LZTR1 variants has not been widely reported in patients with schwannomatosis. So far, SMARCB1 germline mosaicism was reported only in one family and no patients with mosaic LZTR1-associated schwannomatosis have been reported in the literature. The purpose of this study was to evaluate the incidence of mosaic SMARCB1 or LZTR1 variants in patients with schwannomatosis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
